Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6 Pt 2 Suppl 46
pubmed:dateCreated
1989-7-5
pubmed:abstractText
Safe energy parameters for each Sharplan CO2 laser model (734, 1040, 1100A) were established in the laboratory. Ultrasensitive pyroelectric detectors analyzed the precise energy package delivered to the operative field with each of these power setting. Subsequently, 0.6-mm stapedotomy and stapedectomy revisions were performed under simulated operating room conditions while measuring temperature changes in the vestibule with a thermocouple. Table I illustrates safe energy settings for each of the Sharplan CO2 models tested. These power settings produced no more than 0.3 degrees C temperature rise in the vestibule during stapedotomy, and no more than 0.5 degrees C during stapedectomy revision. Following these guidelines, the CO2 laser was then employed to perform stapedotomy and stapedectomy revisions in otosclerosis patients. In over 200 consecutive operations performed under local anesthesia with the CO2 laser, no patient became dizzy intraoperatively while the CO2 laser was applied to the stapes footplate or the oval window neomembrane, confirming the lack of significant caloric effect to the inner ear at these energy settings. More importantly, no patient has yet experienced significant sensorineural hearing loss in the speech range.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0023-852X
pubmed:author
pubmed:issnType
Print
pubmed:volume
99
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
9-12
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
CO2 laser for otosclerosis: safe energy parameters.
pubmed:affiliation
Department of Otolaryngology, Bethesda Hospital, Cincinnati, Ohio.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't